
Keywords: فاکتور نکروز توموری آلفا; IF; intestinal failure; PN; parenteral nutrition; IFALD; intestinal failure associated liver disease; IL-6; interleukin-6; TNF-α; tumor necrosis factor-α; FGF19; fibroblast growth factor 19; FXR; farnesoid nuclear receptor X; NAFLD; nonalcoholic fatty l